Investors cold on Shire deal
Niche drug-maker Shire (SHP) recovers 5.1% to £41.27 after Monday?s 8.2% drop on confirmation it is splashing out £22.2 billion in cash and shares to buy US outfit Baxalta (BXLT:NYSE).The $45.57 a share agreement is a 37.5% premium...
12 January 2016
